In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones
Several 5-benzyl-2,4-thiazolidinediones ( 5– 7) were synthesised and tested as in vitro aldose reductase (ALR2) inhibitors. Most of them, particularly N-unsubstituted 5-benzyl-2,4-thiazolidinediones 5 and (5-benzyl-2,4-dioxothiazolidin-3-yl)acetic acids 7, displayed moderate to high inhibitory activ...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 14; no. 2; pp. 567 - 574 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
15.01.2006
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Several 5-benzyl-2,4-thiazolidinediones (
5–
7) were synthesised and tested as in vitro aldose reductase (ALR2) inhibitors. Most of them, particularly N-unsubstituted 5-benzyl-2,4-thiazolidinediones
5 and (5-benzyl-2,4-dioxothiazolidin-3-yl)acetic acids
7, displayed moderate to high inhibitory activity levels. In detail, the insertion of an acetic chain on N-3 significantly enhanced ALR2 inhibitory potency, leading to acids
7 which proved to be the most effective among the tested compounds. In addition, in N-unsubstituted derivatives
5 the presence of an additional aromatic ring on the 5-benzyl moiety was generally beneficial. In fact, the ALR2 inhibition results of compounds
5–
7, compared to those of the previously assayed corresponding 5-arylidene-2,4-thiazolidinediones, indicated that N-unsubstituted derivatives
5b,
c and
d, which bore an additional aromatic group in the para position of the 5-benzyl residue, were significantly more effective than their 5-arylidene counterparts; in all other cases, the saturation of the exocyclic double bond C
C in 5 brought about a moderate decrease in activity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2005.08.056 |